Psychedelics

Psychedelics Surpass Cannabis With Unprecedented Bipartisan Support In Congress, Says Top VA Official
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
GOP Governors In Vermont And Alaska To Weigh In On Psychedelic-Assisted Therapy Task Force Bills
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
GOP Governors In Vermont And Alaska To Weigh In On Psychedelic-Assisted Therapy Task Force Bills
How Can Amanita Muscaria Mushroom Products Meet Quality And Safety Standards?
Those Who Have Tried And Had Mostly Positive Experiences With Marijuana Or Psychedelics More Likely To Support Legalization, New Survey

Psychedelics Recent News

Thailand Approves Opium, Magic Mushrooms For Medical And Research Purposes
In a landmark shift in drug policy, Thailand's Ministry of Public Health has officially sanctioned the medical and research use of opium and psilocybin mushrooms, commonly known as magic mushrooms, El Planteo reported.
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as a Schedule III controlled substance. 
Divine Supply: How A California Church Became A Psychedelics And Weed Sanctuary Challenging Federal Prohibition
Explore how Dave Hodges' Church of Ambrosia challenges federal laws with spiritual uses of cannabis and psychedelics. Read now!
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
The Canadian-based biopharma company MindBio Therapeutics Corp. CSE: MBIO obtained regulatory approval for a series of clinical trials in women's health using its proprietary LSD drug, MB22001. The company said it is the only one in the world with regulatory approvals of the take-home use of this type of scheduled drug in clinical trials. <
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly
The National Institutes of Health (NIH) recently said it will fund clinical trials on examining the safety and efficacy of psychedelic-assisted therapy in older adults with chronic pain. According to NIH's Wednesday notice, it intends to direct $8.4 million toward research on "classic" psychedelics such as psilocybin, N, N-Dimethyltryptamine (DMT), lysergic acid diethylamide (LSD), and mescaline, as well as methylenedioxymethamphetamine (MDMA). The funding notice also highlighted that roughly 40% of older Americans said they've been living with chronic pain caused by musculoskeletal conditions, neuropathies and cancer. Interestingly the document highlighted that cannabis and ketamine are not "considered psychedelic agents" for the purpose.
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
Tryp Therapeutics finalizes merger with Exopharm, prepares for ASX listing with strategic shareholder benefits. Explore merger details now!
NJ Activists Plant Cannabis Garden On State House Lawn, Fentanyl Replaces MDMA In Fed Drug Testing, Psychedelics Therapy For Vets
NJ activists defy laws with a cannabis garden, Congress advocates MDMA therapy for vets, and fentanyl replaces MDMA in federal tests. Read!
DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
Psychedelic Productivity: Peer Pressure Or Good Career Advice?
A trend of psychedelics being used to improve focus, creativity and general well-being at work is on the rise, especially among a growing group of Silicon Valley entrepreneurs and employees. And, it seems like a last year's warning from the U.S. Food and Drug Administration (FDA) about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders is not affecting its popularity.
Colorado Senate Approves Controversial Bill Restricting Social Media Posts On Substances Like Legal Hemp, Psychedelics
Explore how Colorado's SB24-158 bill reshapes social media discussions on legal cannabis, psychedelics, and its debate on free speech rights.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers